These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3591553)

  • 1. Platelet fibrinogen binding in familial hypercholesterolemia.
    Di Minno G; Cerbone AM; Iride C; Mattioli PL; Postiglione A; Mancini M
    Adv Exp Med Biol; 1987; 210():233-6. PubMed ID: 3591553
    [No Abstract]   [Full Text] [Related]  

  • 2. Thromboxane- and ADP-independent aggregation and exposure of fibrinogen receptors on platelets from patients with familial hypercholesterolemia.
    Cerbone AM; Di Minno G; Postiglione A; Cirillo F; Pannain M; Mattioli PL; Mancini M
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():231-3. PubMed ID: 2988312
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased fibrinogen binding to platelets from patients with familial hypercholesterolemia.
    DiMinno G; Silver MJ; Cerbone AM; Rainone A; Postiglione A; Mancini M
    Arteriosclerosis; 1986; 6(2):203-11. PubMed ID: 3954674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo effect of ticlopidine on fibrinogen-platelet cofactor activity and binding of fibrinogen to platelets.
    Dunn FW; Soria J; Soria C; Thomaidis A; Lee H; Caen JP
    Agents Actions Suppl; 1984; 15():97-104. PubMed ID: 6091425
    [No Abstract]   [Full Text] [Related]  

  • 5. von Willebrand factor can substitute for plasma fibrinogen in ADP-induced platelet aggregation.
    Timmons S; Hawiger J
    Trans Assoc Am Physicians; 1986; 99():226-35. PubMed ID: 3496699
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet aggregation: its relation with ADP-induced fibrinogen binding to platelets and ADP-related membrane enzyme activities.
    Legrand C; Dubernard V; Caen J
    Eur J Biochem; 1984 Aug; 142(3):465-71. PubMed ID: 6088225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of GPIIb-IIIa complex ligands on calcium ion movement and cytoskeleton organization in activated platelets.
    Sinigaglia F; Bisio A; Torti M; Balduini CL; Bertolino G; Balduini C
    Biochem Biophys Res Commun; 1988 Jul; 154(1):258-64. PubMed ID: 3395329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotinylated fibrinogen. A novel probe for monitoring post-ligand-binding events in platelets.
    Hogan M; Mattson JC; Estry DW; Klomparens K
    Ann N Y Acad Sci; 1994 Apr; 714():282-6. PubMed ID: 8017780
    [No Abstract]   [Full Text] [Related]  

  • 9. Membrane receptors for fibrinogen and factor VIII and abnormalities of platelet function. A review.
    Di Minno G; Palladino M; Mattioli PL; Mancini M
    Haematologica; 1985; 70(4):354-7. PubMed ID: 3000900
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinogen interaction with platelets of diabetic subjects.
    Niewiarowski S; Rawala R; Lukasiewicz H; Hershock D; Capitanio AM; Kornecki E; Boden G
    Thromb Res; 1987 May; 46(3):479-89. PubMed ID: 3603436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for prostaglandins and thromboxanes in the exposure of platelet fibrinogen receptors.
    Bennett JS; Vilaire G; Burch JW
    J Clin Invest; 1981 Oct; 68(4):981-7. PubMed ID: 6270196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of glycoprotein IIb-IIIa complex in ristocetin-stimulated platelets as revealed by a monoclonal antibody.
    Hato T
    Nihon Ketsueki Gakkai Zasshi; 1987 Feb; 50(1):129-37. PubMed ID: 3591232
    [No Abstract]   [Full Text] [Related]  

  • 13. Colloidal gold labelling of fibrinogen receptors in epinephrine- and ADP-activated platelet suspensions.
    Oliver JA; Albrecht RM
    Scanning Microsc; 1987 Jun; 1(2):745-56. PubMed ID: 3616571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
    Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
    J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo effects of ticlopidine on human platelets: inhibition of fibrinogen binding by a mechanism independent of thromboxane formation.
    Iovine C; d'Avenia V; Turco S; Mattioli PL; di Minno G
    Agents Actions Suppl; 1984; 15():105-7. PubMed ID: 6592941
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta 3 integrin derived peptide 217-230 inhibits fibrinogen binding and platelet aggregation: significance of RGD sequences and fibrinogen A alpha-chain.
    Lasz EC; McLane MA; Trybulec M; Kowalska MA; Khan S; Budzynski AZ; Niewiarowski S
    Biochem Biophys Res Commun; 1993 Jan; 190(1):118-24. PubMed ID: 8422238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboxane generation by human monocytes enhances platelet function.
    Altieri DC; Mannucci PM
    J Exp Med; 1986 Nov; 164(5):1815-20. PubMed ID: 3772299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulus-response coupling mechanisms in human platelets.
    Rink TJ
    Agents Actions Suppl; 1986; 20():147-69. PubMed ID: 3028101
    [No Abstract]   [Full Text] [Related]  

  • 19. Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. II. Quantal activation parallels platelet capture in stir-associated microaggregation.
    Frojmovic MM; Mooney RF; Wong T
    Biophys J; 1994 Nov; 67(5):2069-75. PubMed ID: 7858144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine.
    Di Minno G; Cerbone AM; Mattioli PL; Turco S; Iovine C; Mancini M
    J Clin Invest; 1985 Feb; 75(2):328-38. PubMed ID: 3156146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.